Sendai virus, the mouse parainfluenza type 1: A longstanding pathogen that remains up-to-date

[en] Biologically speaking, Sendai virus (SeV), the murine parainfluenza virus type 1, is perceived as a common respiratory pathogen that is endemic in many rodent colonies throughout the world. Currently it is believed that SeV is the leading cause of pneumonia in mice and together with the mouse hepatitis viruses, is the most prevalent and important of the naturally occurring infections of mice. The scientific community also considers SeV as the archetype organism of the Paramyxoviridae family because most of the basic biochemical, molecular and biologic properties of the whole family were derived from its own characteristics. Recently, scientific interest for this old pathogen has re-emerged, this time because of its potential value as a vector for gene transfer. This review aimed at drawing an exhaustive picture of this multifaceted pathogen. (c) 2006 Elsevier Ltd. All rights reserved.

Disciplines :

Immunology & infectious disease

Author, co-author :

Faisca, Pedro; Université de Liège - ULiège > Département de Morphologie et Pathologie > Pathologie spéciale et autopsies

Desmecht, Daniel ; Université de Liège - ULiège > Département de Morphologie et Pathologie > Pathologie spéciale et autopsies

Language :

English

Title :

Sendai virus, the mouse parainfluenza type 1: A longstanding pathogen that remains up-to-date

Publication date :

2007

Journal title :

Research in Veterinary Science

ISSN :

0034-5288

eISSN :

1532-2661

Publisher :

W B Saunders Co Ltd, London, United Kingdom

Volume :

Issue :

Pages :

115-125

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 22 December 2009

Statistics

Number of views

60 (2 by ULiège)

Number of downloads

0 (0 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

Bibliography

Ali A., and Nayak A. Assembly of Sendai virus: M protein interacts with F and HN proteins and with the cytoplasmic tail and transmembrane domain of F protein. Virology 276 (2000) 289-303
Alymova I., Taylor G., Takimoto T., Lin T., Chand P., Babu Y., Li C., Xiong X., and Portner A. Efficacy of novel hemagglutinin-neuraminidase inhibitors BCX 2798 and BCX 2855 against human parainfluenza viruses in vitro and in vivo. Antimicrobial Agents and Chemotherapy 48 (2004) 1495-1502
Anderson M., Bainbridge D., Pattison J., and Heath R. Cell-mediated immunity to Sendai virus infection in mice. Infection and Immunity 15 (1977) 239-244
Appell L., Kovatch R., Reddecliff J.M., and Gerone P.J. Pathogenesis of Sendai virus infection in mice. American Journal of Veterinary Research 32 (1971) 1835-1841
Bhatt P.N., and Jonas A.M. An epizootic of Sendai infection with mortality in a barrier maintained mouse colony. American Journal of Epidemiology 100 (1974) 222-229
Blanchard L., Tarbouriech N., Blackledge M., Timmins P., Burmeister W.P., Ruigrok R.W., and Marion D. Structure and dynamics of the nucleocapsid-binding domain of the Sendai virus phosphoprotein in solution. Virology 319 (2004) 201-211
Blandford G., Cureton R.J., and Heath R.B. Studies of the immune response in Sendai virus infection of mice. Journal of Medical Microbiology 4 (1971) 351-356
Blitzer M., Armeanu S., Lauer U.M., and Neubert W.J. Sendai virus vectors as an emerging negative-strand RNA viral vector system. The Journal of Gene Medicine 5 (2003) 543-553
Blumberg B.M., Giorgi C., Rose K., and Kolakofsky D. Sequence determination of the Sendai virus fusion protein gene. Journal of General Virology 66 (1985) 317-331
Bowman M.C., Smallwood S., and Moyer S.A. Dissect ion of individual functions of the Sendai virus phosphoprotein in transcription. Journal of Virology 73 (1999) 6474-6483
Breider M.A., Adams L.G., and Womack J.E. Influence of interferon in natural resistance of mice to Sendai virus pneumonia. American Journal of Veterinary Research 48 (1987) 1746-1750
Brownstein D.G., and Winkler S. Genetic resistance to lethal Sendai virus pneumonia: virus replication and interferon production in C57BL/6J and DBA/2J mice. Laboratory Animal Science 36 (1986) 126-129
Brownstein D.G., Smith A., and Johnson E. Sendai virus infection in genetically resistant and susceptible mice. American Journal of Pathology 105 (1981) 156-163
Castleman W.L., Sorkness R.L., Lemanske Jr. R.F., and McAllister P.K. Viral bronchiolitis during early life induces increased numbers of bronchiolar mast cells ans airway hyperresponsiveness. American Journal of Pathology 137 (1990) 821-831
Chanock R.M., Murphy B.R., and Collins P.L. Parainfluenza viruses. In: Fields B.N., et al. (Ed). Fields Virology. fourth ed. (2001), Lippincott Williams & Wilkins, Philadelphia, PA 1341-1379
Chen Y., Webster R.G., and Woodland D.L. Induction of CD8+ T cell responses to dominant and subdominant epitopes and protective immunity to Sendai virus infection by DNA vaccination. Journal of Immunology 160 (1998) 2425-2432
Compton S.R., and Riley L.K. Detection of infectious agents in laboratory rodents: Traditional and molecular techniques. Comparative Medicine 51 (2001) 113-119
Coronel E.C., Murti K.G., Takimoto T., and Portner A. Nucleocapsid incorporation into parainfluenza virus is regulated by specific interaction with matrix protein. Journal of Virology 75 (2001) 1117-1123
Curran J.A., and Kolakofsky D. Identification of an additional Sendai virus non-structural protein encoded by the P/C mRNA. Journal of General Virology 68 (1987) 2515-2519
Curran J.A., and Kolakofsky D. Scanning independent ribosomal initiation of the Sendai virus Y proteins in vitro and in vivo. EMBO Journal 8 (1989) 521-526
Curran J.A., Boeck R., and Kolakofsky D. The Sendai virus P gene expresses both an essential protein and an inhibitor of RNA synthesis by shuffling modules via mRNA editing. EMBO Journal 10 (1991) 3079-3085
Descoteaux J.P., Boulay G., and Potworowski E. An epizzotic of parainfluenza virus type 1 in a group of C57B16 mice. Canadian Veterinary Journal 21 (1980) 21-23
Eaton G.J., Lerro A., Custer R.P., and Crane A.R. Eradication of Sendai pneumonitis from a conventional mouse colony. Laboratory Animal Science 32 (1982) 384-386
Erlt H.C., Gerlich W., and Koszinowski U.H. Detection of antibodies to Sendai virus by enzyme-linked immunosorbent assay (ELISA). Journal of Immunological Methods 28 (1979) 163-176
Ertl H.C., Brown E.G., and Finberg R.W. Sendai virus-specific T cell clones. II. Induction of interferon production by Sendai virus-specific T helper cell clones. European Journal of Immunology 12 (1982) 1051-1053
Faisca P., Bui Tran Anh D., and Desmecht D. Sendai virus-induced alterations in lung structure/function correlate with viral loads and reveal a wide resistance/susceptibility spectrum among mouse strains. American Journal of Physiology - Lung Cellular and Molecular Physiology 289 (2005) 777-787
Fujiwara K., Taenaka S., and Shumiya S. Carrier state of antibody and viruses in a mouse breeding colony persistently infected with Sendai and mouse hepatitis viruses. Laboratory Animal Science 26 (1976) 153-159
Fukumi H., Nishikawa F., and Kiayama T. A pneumotropic virus from mice causing hemagglutination. Japanese Journal of Medical Science & Biology 7 (1954) 345-363
Garcin D., Latorre P., and Kolakofsky D. Sendai virus C proteins counteract the interferon-mediated induction of an antiviral state. Journal of Virology 73 (1999) 6559-6565
Garcin D., Curran J., Itoh M., and Kolakofsky D. Longer and shorter forms of Sendai virus C proteins play different roles in modulating the cellular antiviral response. Journal of Virology 75 (2001) 6800-6807
Gotoh B., Komatsu T., Takeuchi K., and Yokoo J. Paramyxovirus accessory proteins as interferon antagonists. Microbiology and Immunology 45 (2001) 787-800
Gotoh B., Takeuchi K., Komatsu T., and Yokoo J. The STAT2 activation process is a crucial target of Sendai virus C protein for the blockade of alpha interferon signaling. Journal of Virology 77 (2003) 3360-3370
Hidaka Y., Kanda T., Iwasaki K., Nomoto A., Shioda A., and Shibuta H. Nucleotide sequence of a Sendai virus genome region covering the entire M gene and the 3′ proximal 1013 nucleotides of the F gene. Nucleic Acids Research 12 (1984) 7965-7973
Homma M. Trypsin action on the growth of Sendai virus in tissue culture cells. I. Restoration of the infectivity for L cells by direct action of trypsin on L cell-borne Sendai virus. Journal of Virology 8 (1971) 619-629
Homma M., and Ohuchi M. Trypsin action on the growth of Sendai virus in tissue culture cells. III. Structural difference of Sendai viruses grow in eggs and tissue culture cells. Journal of Virology 12 (1973) 1457-1465
Hou S., Doherty P.C., Zijlstra M., Jaenisch R., and Katz J.M. Delayed clearance of Sendai virus in mice lacking class I MCH-restricted CD8+ T cells. The Journal of Immunology 149 (1992) 1319-1325
Hurwitz J.L., Soike K.F., Sangster M.Y., Portner A., Sealy R.E., Dawson D.H., and Coleclough C. Intranasal Sendai virus vaccine protects African green monkeys from infection with human parainfluenza virus-type one. Vaccine 15 (1997) 533-540
Inoue M., Tokusumi Y., Ban H., Kanaya T., Shirakura M., Tokusumi T., Hirata T., Nagai Y., Iida A., and Hasegawa M. A new Sendai virus vector deficient in the matrix gene does not form virus particles and shows extensive cell-to-cell spreading. Journal of Virology 77 (2003) 6419-6429
Ishida N., and Homma M. Sendai virus. Advances in Virus Research 23 (1978) 349-383
Itoh Y., Yamamoto F., Takano M., Maeno K., Shimokata M., Iinuma K., Hara K., and Iijima S. Detection of cellular receptors for Sendai virus in mouse tissue sections. Archives of Virology 75 (1983) 103-113
Itoh M., Shibuta H., and Homma M. Single amino acid substitution of Sendai virus at the cleavage site of the fusion protein confers trypsin resistance. Journal of General Virology 68 (1987) 2939-2944
Itoh T., Saitoh M., and Iwai H. Comparison of lung viral titers in susceptible and resistant inbred mouse strains against Sendai virus infection. Experimental Animals 38 (1989) 269-273
Itoh T., Iwai H., and Ueda K. Comparative lung pathology of inbred strains of mice resistant and susceptible to Sendai virus infection. Journal of Veterinary Medical Science 53 (1991) 275-279
Itoh M., Isegawa Y., Hotta H., and Homma M. Isolation of an avirulent mutant of Sendai virus with two amino acid mutations from a highly virulent field strain through adaptation to LLC-MK2 cells. Journal of General Virology 78 (1997) 3207-3215
Iwai H., Yamaguchi R., Otsuka Y., Ueda K., and Saito M. Immunoglobulin classes of anti-Sendai virus antibody detected by ELISA in infected nude mouse serum. Microbiology and Immunology 28 (1983) 481-491
Jakab G.J. Interactions between Sendai virus and bacterial pathogens in the murine lung: a review. Laboratory Animal Science 31 (1981) 170-177
Jessen R.H., Emancipator S.N., Jacobs G.H., and Nedrud J.G. Experimental IgA-IgG nephropathy induced by a viral respiratory pathogen. Dependance on antigen form and immune status. Laboratory Investigation 67 (1992) 379-386
Kato A., Kiyotani K., Sakai T., Yoshida T., and Nagai Y. The paramyxovirus, Sendai virus, V protein encodes a luxury function required for viral pathogenesis. EMBO Journal 16 (1997) 578-587
Kato A., Cortese-Grogan C., Moyer S.A., Sugahara F., Sakaguchi T., Kubota T., Otusuki N., Kohase M., Tashiro M., and Nagai Y. Characterization of the amino acid residues of Sendai virus C protein that are critically involved in its interferon antagonism and RNA synthesis down-regulation. Journal of Virology 78 (2004) 7443-7454
Kido H., Yokogoshi Y., Sakai K., Tashiro M., Kishino Y., Fukutomi A., and Katunuma N. Isolation and characterization of a novel trypsin-like protease found in rat bronchiolar epithelial Clara cells: a possible activator of the viral fusion glycoprotein. Journal of Biological Chemistry 267 (1992) 13573-13579
Kinoh H., Inoue M., Washizawa K., Yamamoto T., Fujikawa S., Tokusumi Y., Iida A., Nagai Y., and Hasegawa M. Generation of a recombinant Sendai virus that is selectively activated and lyses human tumor cells expressing matrix metalloproteinases. Gene Therapy 11 (2004) 1137-1145
Kobayashi N., Bagheri N., Nedrud J.G., Strieter R.M., Tomino Y., Lamm M.E., and Emancipator S.N. Differential effects of Sendai virus infection on mediator synthesis by mesangial cells from two mouse strains. Kidney International 64 (2003) 1675-1984
Kotani H., Nakajima T., Lai S., Morishita R., and Kaneda Y. The HVJ-envelope as an innovative system for cardiovascular disease. Current Gene Therapy 4 (2004) 183-194
Kraft V., and Meyer B. Diagnosis of murine infections in relation to test methods employed. Laboratory Animal Science 36 (1986) 271-276
Kumar A., Sorkness R.L., Kaplan M.R., and Lemanske Jr. R.F. Chronic, episodic, reversible airway obstruction after viral bronchiolitis in rats. American Journal of Respiratory and Critical Care Medicine 155 (1997) 130-134
Lamb R.A., and Kolakfsky D. Paramyxoviridae: The viruses and their replication. In: Fields B.N., et al. (Ed). Fields Virology. fourth ed. (2001), Lippincott Williams & Wilkins, Philadelphia, PA 1305-1340
Latorre P., Kolakofsky D., and Curran J. Sendai virus Y proteins are initiated by a ribosomal shunt. Molecular and Cellular Biology 18 (1998) 5021-5031
Li H.O., Zhu Y.F., Asakawa M., Kumar, Hirata T., Ueda Y., Lee Y.S., Fukumara M., Iida A., Kato A., Nagai Y., and Hasegawa M. A cytoplasmic RNA vector derived from non-transmissible Sendai virus with efficient gene transfer and expression. Journal of Virology 74 (2000) 6564-6569
Li, H.O., Zhu, Y.F., Ueda, Y., Hasegawa, M., Iida, A., Tokito, F., Hirata, T., Tokusumi, T., Kumar, H., Asakawa, M., 2000. Paramyxoviridae virus vector defective in envelope gene. Patent PCT/WO 00/70070.
Masaki I., Yonemitsu Y., Yamashita A., Sata S., Tanii M., Komori K., Nakagawa K., Hou X., Nagai Y., Hasegawa M., Sugimachi K., and Sueishi K. Angiogenic gene therapy for experimental critical limb ischemia: acceleration of limb loss by overexpression of vascular endothelial growth factor 165 but not of fibroblast growth factor-2. Circulatory Research 90 (2002) 966-973
Mikus L.D., Rosenthal L.A., Sorkness R.L., and Lemanske Jr. R.F. Reduced interferon-γ secretion by natural killer cells from rats susceptible to postviral chronic airway dysfunction. American Journal of Respiratory Cell and Molecular Biology 24 (2001) 74-82
Miyamae T. Differential invasion by Sendai virus of abdominal parenchymal organs and brain tissues in cortisone-and cyclophosphamide-based immunosupressed mice. Journal of Veterinary Medical Science 67 (2005) 369-377
Mo X.Y., Sarawar S.R., and Doherty P.C. Induction of cytokines in mice with parainfluenza pneumonia. Journal of Virology 69 (1995) 1288-1291
Mochizuki Y., Tashiro M., and Homma M. Pneumopathogenicity in mice of a Sendai virus mutant, TSrev-58, is accompanied by in vitro activation with trypsin. Journal of Virology 62 (1988) 3040-3042
Morgan E.M., and Rakestraw K.M. Sequence of the Sendai virus L gene: open reading frames upstream of the main coding region suggest that the gene may be polycistronic. Virology 154 (1986) 31-40
Nakagawa M., Saito M., Kinoshita K., Suzuki E., and Imaizumi K. Pathogenicity of Sendai virus in mice cage-mated with their offsprings. Japanese Journal of Veterinary Science 42 (1980) 337-344
Okano S., Yonemitsu Y., Nagata S., Onimaru M., Nakagawa K., Tomita Y., Kishihara K., Hashimoto S., Nakashima Y., Sugimachi K., Hasegawa M., and Sueishi K. Recombinant Sendai virus vectors for activated T lymphocytes. Gene Therapy 10 (2003) 1381-1391
Parker J.C., and Reynolds R.K. Natural history of Sendai virus infection in mice. American Journal of Epidemiology 88 (1968) 112-125
Parker J.C., and Ritcher C.B. Viral diseases of the respiratory system. In: Foster H.L., et al. (Ed). The mouse in biomedical research (1982), Academic Press, New York 110-158
Parker J.C., Tennant R.W., Ward T.G., and Rowe W.P. Enzootic Sendai virus infection in mouse breeder colonies within the United States. Science 146 (1964) 836-838
Parker J.C., Whiteman M., and Ritcher C. Susceptibility of inbred and outbred mouse strains to Sendai virus and prevalence of infection in laboratory rodents. Infection and Immunity 19 (1978) 123-130
Percy D.H., Auger D.C., and Croy B.A. Signs and lesions of experimental Sendai virus infection in two genetically distinct strains of SCID/Beige mice. Veterinary Pathology 31 (1994) 67-73
Pinkenburg O., Vogelmeier C., Bossow S., Neubert W.J., Lutz R.B., Ungerechts G., Lauer U.M., Bitzer M., and Bals R. Recombinant Sendai virus for efficient gene transfer to human airway epithelium. Experimental Lung Research 30 (2004) 83-96
Profeta M.L., Lief F.S., and Plotkin S.A. Enzootic Sendai infection in laboratory hamsters. American Journal of Epidemiology 89 (1969) 316-324
Qiang L., Yi J., and Fu-de C. Melanoma vaccine based on the vector of membrane fusogenic liposomes. Pharmazie 59 (2004) 263-267
Sakaguchi T., Kiyotani K., Sakaki M., Fujii Y., and Yoshida T. A field isolate of Sendai virus: its high virulence to mice and genetic divergence from prototype strains. Archives of Virology 135 (1994) 159-164
Sakaguchi T., Kiyotani K., Watanabe H., Huang C., Fukuhara N., Fujii Y., Shimazu Y., Sugahara F., Nazai Y., and Yoshida T. Masking of the contribution of V protein to Sendai virus pathogenesis in an infection model with a highly virulent field isolate. Virology 13 (2003) 581-587
Sanderson C.M., McQueen N.L., and Nayak D.P. Sendai virus assembly: M protein binds to viral glycoproteins in transit through the secretory pathway. Journal of Virology 67 (1993) 651-663
Sangster M., Hyland L., Sealy R., and Coleclough C. Distinctive kinetics of the antibody-forming cells response to Sendai virus infection of mice in different anatomical compartments. Virology 207 (1995) 287-291
Scheid A., and Choppin P.W. Identification of biological activities of paramyxovirus glycoproteins. Activation of cell fusion, hemolysis, and infectivity by proteolytic cleavage of an inactive precursor protein of Sendai virus. Virology 57 (1974) 475-490
Shioda T., Hidaka Y., Kanda T., Shibuta H., Nomoto A., and Iwasaki K. Sequence of 3687 nucleotides from the 3′ end of Sendai virus genome RNA and the predicted amino acid sequences of viral NP, P and C proteins. Nucleic Acids Research 21 (1983) 7317-7330
Shioda T., Iwasaki K., and Shibuta H. Determination of the complete nucleotide sequence of the Sendai virus genome RNA and the predicted amino acid sequences of the F, HN, and L proteins. Nucleic Acids Research 14 (1986) 1545-1563
Shiotani A., Fukumura M., Maeda M., Hou X., Inoue M., Kanamori T., Komaba S., Washizawa K., Fujikawa S., Yamamoto T., Kanodo C., Watabe K., Fukuda H., Saito K., Sakai Y., Nagai Y., Kanzaki J., and Hasegawa M. Skeletal muscle regeneration after insulin-like growth factor I gene transfer by recombinant Sendai virus vector. Gene Therapy 8 (2001) 1043-1050
Shirakura M., Inoue M., Fujikawa S., Washizawa K., Komaba S., Maeda M., Watabe K., Yoshikawa Y., and Hasegawa M. Postischemic administration of Sendai virus carrying neurotropic factor genes prevents delayed neuronal death in gerbils. Gene Therapy 11 (2004) 784-790
Sorkness R.L., and Tuffaha A. Contribution of airway closure to chronic postbronchiolitis airway dysfunction in rats. Journal of Applied Physiology 96 (2004) 904-910
Stricker R., and Roux L. The major glycoprotein of Sendai virus is dispensable for efficient virus particle budding. Journal of General Virology 72 (1991) 1703-1707
Sugita K., Maru M., and Sato K. A sensitive Plaque assay for Sendai virus in an established line of monkey kidney cells. Japanese Journal of Microbiology 18 (1974) 262-264
Sugita K., Maru M., and Sato K. Biological properties of plaque-size variants of Sendai virus. Microbiology and Immunology 25 (1981) 353-360
Suzuki E., Noguchi A., and Takeda H. Detection of antibodies to Sendai virus in mouse sera by enzyme-linked immunosorbent assay (ELISA). Japanese Journal of Medical Science & Biology 40 (1987) 109-117
Takimoto T., Murti K.G., Bousse T., Scroggs R.A., and Portner A. Role of matrix and fusion proteins in budding of Sendai virus. Journal of Virology 75 (2001) 11384-11391
Takimoto T., Hurwitz J.L., Coleclough C., Prouser C., Krishnamurthy S., Zhan X., Boud K., Scroggs R.A., Brown B., Nagai Y., Portner A., and Slobod K.S. Recombinant Sendai virus expressing the G glycoprotein of respiratory syncytial virus (RSV) elicits immune protection against RSV. Journal of Virology 78 (2004) 6043-6047
Tashiro M., and Homma M. Pneumotropism of Sendai virus in relation to protease-mediated activation in mouse lungs. Infection and Immunity 39 (1983) 879-888
Tashiro M., Yamakawa K., Tobita K., Klenk H.-D., Rott R., and Seto J.T. Organ tropism of Sendai virus in mice: proteolytic activation of the fusion glycoprotein in mouse organs and budding site at the bronchial epithelium. Journal of Virology 64 (1990) 3627-3634
Tashiro M., Yokogoshi Y., Tobita K., Seto J.T., Rott R., and Kido H. Tryptase Clara, an activating protease for Sendai virus in rat lungs, is involved in pneumopathogenicity. Journal of Virology 64 (1992) 3627-3634
Taylor K., and Copley C.G. Detection of rodent RNA viruses by polymerase chain reaction. Laboratory Animals 28 (1993) 31-34
Tozawa H., Watanabe M., and Ishida N. Structural components of Sendai virus. Serological and physicochemical characterization of hemagglutinin subunit associated with neurominidase activity. Virology 120 (1973) 329-339
Vidal S., Curran J., and Kolakofsky D. Editing of the Sendai virus P/C mRNA by G insertion occurs during mRNA synthesis via a virus-encoded activity. Journal of Virology 64 (1990) 239-246
Wagner A.M., Loganbill J.K., and Besselsen D.G. Detection of Sendai virus and pneumonia virus of mice by use of fluorogenic nuclease reverse transcriptase polymerase chain reaction analyses. Comparative Medicine 53 (2003) 173-177
Ward J.M. Naturally occurring Sendai virus disease of mice. Laboratory Animal Science 24 (1974) 938-942
Ward G.A., and Jakab G.J. Alterations in lung macrophage antimicrobial activity associated with viral pneumonia. Infection and Immunity 26 (1979) 492-497
Ward J.M., Houchens D.P., Collins M.J., Young D.M., and Reagan R.L. Naturally-occurring Sendai virus infection of athymic nude mice. Veterinary Pathology 13 (1976) 36-46
Ward G.A., Jakab G.J., Chan T.W., and Tsan M.F. Effects of viral pneumonia on lung macrophage lysosomal enzymes. Infection and Immunity 24 (1979) 577-579
Yamaguchi R., Iwai H., and Ueda K. Variation of virulence and other properties among Sendai virus strains. Microbiology and Immunology 32 (1988) 235-240
Yonemitsu Y., Kitson C., Ferrari S., Farley R., Griesenbach U., Judd D., Steel R., Scheid P., Zhu J., Jeffery P.K., Kato A., Hasan M.K., Nagai Y., Masaki I., Fukumura M., Hasegawa M., Geddes D.M., and Alton E.W. Efficient gene transfer to airway epithelium using recombinant Sendai virus. Natural Biotechnology 18 (2000) 970-973
Zenner L., and Regnault J.P. Ten-year long monitoring of laboratory mouse and rat colonies in French facilities: a retrospective study. Laboratory Animals 34 (2000) 76-83
Zhong W., Marshall D., Coleclough C., and Woodland D.L. CD4+ T cell priming accelerates the clearance of Sendai virus in mice, but has a negative effect on CD8+ T cell memory. Journal of Immunology 164 (2000) 3274-3282
Zhong W., Roberts A.D., and Woodland D.L. Antibody-independent antiviral function of memory CD4+ T cells in vivo requires regulatory signals from CD8+ effector T cells. Journal of Immunology 167 (2001) 1379-1386
Zurcher C., Burek J.D., Van Nunen M.C., and Meihuizen S.P. A naturally occurring epizootic caused by Sendai virus in breeding and aging rodent colonies. 1 Infection in the mouse. Laboratory Animal Science 27 (1977) 955-962